Purification_NN and_CC Identification_NN of_IN Secernin_NP ,_, a_DT Novel_NP Cytosolic_NP Protein_NP that_WDT Regulates_VBZ Exocytosis_NN in_IN Mast_NP Cells_NP After_IN permeabilization_NN with_IN the_DT pore-forming_JJ toxin_NN streptolysin-O_NN mast_NN cells_NNS can_MD be_VB triggered_VBN to_TO secrete_VB by_IN addition_NN of_IN both_DT calcium_NN and_CC a_DT GTP_NP analogue_NN ._SENT If_IN stimulation_NN is_VBZ delayed_VBN after_IN permeabilization_NN ,_, there_EX is_VBZ a_DT progressive_JJ decrease_NN in_IN the_DT extent_NN of_IN secretion_NN upon_IN stimulation_NN ,_, eventually_RB leading_VBG to_TO a_DT complete_JJ loss_NN of_IN the_DT secretory_JJ response_NN ._SENT This_DT loss_NN of_IN secretory_JJ response_NN can_MD be_VB retarded_VBN by_IN the_DT addition_NN of_IN cytosol_NN from_IN other_JJ secretory_JJ tissues_NNS ,_, demonstrating_VBG that_IN the_DT response_NN is_VBZ dependent_JJ on_IN a_DT number_NN of_IN cytosolic_JJ proteins_NNS ._SENT We_PP have_VBP used_VBN this_DT as_IN the_DT basis_NN of_IN a_DT bioassay_NN to_TO purify_VB Secernin_NP 1_CD ,_, a_DT novel_JJ 50-kDa_NP cytosolic_JJ protein_NN that_WDT appears_VBZ to_TO be_VB involved_VBN in_IN the_DT regulation_NN of_IN exocytosis_NN from_IN peritoneal_JJ mast_NN cells_NNS ._SENT Secernin_NN 1_CD increases_NNS both_CC the_DT extent_NN of_IN secretion_NN and_CC increases_VBZ the_DT sensitivity_NN of_IN mast_NN cells_NNS to_TO stimulation_NN with_IN calcium_NN ._SENT Mast_NN cells_NNS are_VBP secretory_JJ cells_NNS found_VBN on_IN the_DT mucosal_JJ and_CC serosal_JJ surfaces_NNS of_IN tissues_NNS throughout_IN the_DT body_NN where_WRB they_PP are_VBP involved_VBN in_IN the_DT allergic_JJ response_NN ._SENT The_DT cells_NNS can_MD be_VB activated_VBN by_IN the_DT cross-linking_NN of_IN high-affinity_NN IgE_NN receptors_NNS by_IN antigen-specific_JJ IgE_NP that_WDT leads_VBZ to_TO activation_NN of_IN phospholipase_NN C_NP ,_, generating_VBG IP3_NP that_WDT subsequently_RB causes_VBZ a_DT release_NN of_IN calcium_NN from_IN cytosolic_JJ stores_NNS and_CC thus_RB triggers_VBZ secretion_NN ._SENT The_DT mast_NN cells_NNS secrete_VBP a_DT variety_NN of_IN inflammatory_JJ mediators_NNS ,_, including_VBG histamine_NN ,_, from_IN granules_NNS that_WDT contain_VBP many_JJ lysosomal_JJ markers_NNS ._SENT The_DT presence_NN of_IN lysosomal_JJ markers_NNS in_IN the_DT secretory_JJ granules_NNS of_IN mast_NN cells_NNS and_CC other_JJ secretory_JJ cells_NNS of_IN hemopoietic_JJ lineage_NN (_( such_JJ as_IN basophils_NNS ,_, cytotoxic_JJ T_NN cells_NNS ,_, natural_JJ killer_NN cells_NNS ,_, neutrophils_NNS ,_, eosinophils_NNS ,_, and_CC macrophages_NNS )_) has_VBZ led_VBN to_TO the_DT suggestion_NN that_IN these_DT secretory_JJ granules_NNS are_VBP not_RB derived_VBN from_IN the_DT classical_JJ secretory_JJ pathway_NN ,_, but_CC are_VBP derived_VBN from_IN the_DT lysosomal_JJ pathway_NN ._SENT Permeabilization_NN of_IN secretory_JJ cells_NNS with_IN detergents_NNS such_JJ as_IN digitonin_NN ,_, bacterial_JJ toxins_NNS such_JJ as_IN Streptolysin-O_NP (_( SLO_NP )_) or_CC by_IN mechanical_JJ disruption_NN allows_VBZ exocytosis_NN to_TO be_VB triggered_VBN by_IN the_DT addition_NN of_IN buffered_VBN calcium_NN solutions_NNS ,_, bypassing_VBG the_DT need_NN for_IN activation_NN of_IN a_DT triggering_VBG receptor_NN and_CC associated_JJ signal_NN transduction_NN events_NNS ._SENT In_IN mast_NN cells_NNS an_DT absolute_JJ requirement_NN for_IN guanine_NN nucleotides_NNS has_VBZ been_VBN reported_VBN ,_, unlike_IN neuroendocrine_NN cells_NNS where_WRB guanine_NN nucleotides_NNS appear_VBP to_TO have_VB a_DT modulatory_JJ role_NN ._SENT This_DT has_VBZ led_VBN to_TO the_DT identification_NN of_IN a_DT number_NN of_IN GTP_NP binding_JJ proteins_NNS including_VBG Gialpha3_NP ,_, betagamma_NN subunits_NN ,_, rac_NN ,_, rho_NN ,_, and_CC cdc42_NN ,_, which_WDT all_RB appear_VBP to_TO regulate_VB secretion_NN in_IN mast_NN cells_NNS ._SENT Although_IN the_DT final_JJ fusion_NN event_NN is_VBZ mediated_VBN by_IN the_DT SNAP/NSF/SNARE_NP system_NN in_IN both_DT mast_NN cells_NNS ,_, neurons_NNS and_CC neuroendocrine_NN cells_NNS ,_, it_PP is_VBZ possible_JJ that_IN the_DT origin_NN of_IN these_DT secretory_JJ granules_NNS accounts_NNS for_IN the_DT differences_NNS observed_VBD in_IN the_DT regulation_NN of_IN secretion_NN in_IN these_DT cells_NNS when_WRB compared_VBN with_IN the_DT more_RBR commonly_RB studied_VBN neuroendocrine_NN systems_NNS ._SENT After_IN permeabilization_NN secretory_JJ cells_NNS leak_VBP cytosolic_JJ proteins_NNS ,_, leading_VBG to_TO a_DT progressive_JJ loss_NN of_IN responsiveness_NN to_TO Ca2+_NP and_CC nucleotides_NNS ._SENT This_DT loss_NN of_IN response_NN or_CC rundown_NN can_MD be_VB slowed_VBN by_IN the_DT provision_NN of_IN exogenous_JJ cytosol_NN and_CC has_VBZ been_VBN used_VBN as_IN the_DT basis_NN of_IN a_DT bioassay_NN in_IN mast_NN cells_NNS ,_, chromaffin_NN cells_NNS ,_, and_CC PC12_NP and_CC GH3_NP cells_NNS to_TO purify_VB cytosolic_JJ proteins_NNS that_WDT regulate_VBP secretion_NN from_IN these_DT cells_NNS ._SENT We_PP have_VBP previously_RB shown_VBN that_IN a_DT rac/RhoGDI_NN complex_NN isolated_VBN from_IN bovine_JJ brain_NN cytosol_NN partially_RB restores_VBZ secretory_JJ responsiveness_NN in_IN Streptolysin-O_NP --_: permeabilized_JJ mast_NN cells_NNS ._SENT A_DT number_NN of_IN other_JJ activities_NNS were_VBD partially_RB purified_VBN during_IN the_DT purification_NN of_IN the_DT rac/rhoGDI_NN complex_NN ._SENT Here_RB we_PP report_VBP the_DT full_JJ purification_NN and_CC identification_NN of_IN a_DT second_JJ brain_NN cytosolic_JJ protein_NN ,_, Secernin_NP 1_CD (_( Secern_NN is_VBZ an_DT archaic_JJ English_JJ term_NN for_IN secrete_VB )_) ,_, which_WDT is_VBZ also_RB capable_JJ of_IN regulating_VBG exocytosis_NN in_IN permeabilized_JJ mast_NN cells_NNS ._SENT Frozen_VBN bovine_JJ brains_NNS were_VBD purchased_VBN from_IN First_NP Link_NP UK_NP (_( Brierley_NP Hill_NP ,_, West_NP Midlands_NP ,_, UK_NP )_) ._SENT Male_NP Sprague_NP Dawley_NP rats_NNS were_VBD purchased_VBN from_IN B&K_NP Universal_NP Ltd._NP (_( Hull_NP ,_, UK_NP )_) ._SENT GTP-gamma-S_NNS and_CC bovine_JJ serum_NN albumin_NN was_VBD purchased_VBN from_IN Roche_NP Diagnostics_NP Ltd._NP (_( Lewes_NP ,_, East_NP Sussex_NP ,_, UK_NP )_) ._SENT Streptolysin-O_NP (_( Murex_NP formulation_NN )_) was_VBD purchased_VBN from_IN Corgenix_NP Biotech_NP Limited_NP (_( Temple_NP Hill_NP ,_, Dartford_NP ,_, Kent_NP ,_, UK_NP )_) ._SENT Ceramic_JJ hydroxyapatite_NN column_NN was_VBD purchased_VBN from_IN (_( Hemel_NP Hempstead_NP ,_, UK_NP )_) ,_, and_CC all_DT other_JJ chromatography_NN columns_NNS were_VBD purchased_VBN from_IN Amersham-Pharmacia_NP (_( Amersham_NP ,_, UK_NP )_) ._SENT Donkey_NN anti-rabbit_NN horseradish_NN peroxidase_NN (_( HRP_NP )_) antibody_NN was_VBD purchased_VBN from_IN Amersham-Pharmacia_NP ._SENT The_DT GATEWAY_NP cloning_VBG system_NN and_CC ThermalAce_NP DNA_NP polymerase_NN kit_NN was_VBD obtained_VBN from_IN Invitrogen_NP ,_, Life_NP Technologies_NPS (_( Paisley_NP ,_, UK_NP )_) ._SENT The_DT human_JJ cDNA_NN clone_NN of_IN the_DT gene_NN KIAA0193_NP was_VBD obtained_VBN from_IN the_DT Kazusa_NP DNA_NP Research_NP Institute_NP (_( Kisararazu_NP ,_, Chiba_NP ,_, Japan_NP )_) and_CC inserted_VBN in_IN the_DT pBluescript_JJ SK+_NP vector_NN ._SENT All_DT other_JJ chemicals_NNS used_VBN were_VBD of_IN the_DT highest_JJS quality_NN available_JJ from_IN standard_JJ commercial_JJ sources_NNS ._SENT Experimental_JJ Procedures_NNS |_SYM Secretion_NN Measurements_NNS ._SENT |_SYM Cells_NP were_VBD obtained_VBN by_IN peritoneal_JJ lavage_NN of_IN male_JJ Sprague_NP Dawley_NP rats_NNS (_( >300_JJ g_NN )_) ,_, and_CC mast_NN cells_NNS were_VBD purified_VBN to_TO >98_JJ %_NN purity_NN by_IN centrifugation_NN through_IN Percoll_NP as_IN previously_RB described_VBN ._SENT Cells_NNS ,_, suspended_VBN in_IN assay_NN buffer_NN (_( 137_CD mM_NP NaCl_NP ,_, 2.7_CD mM_NP KCl_NP ,_, 1_CD mM_NP MgCl2_NP ,_, 20_CD mM_NP piperazine-N,N'-bis(2-ethanesulfonic_JJ acid_NN )_) ,_, pH_NN 6.8_CD )_) supplemented_VBD with_IN 1_CD mg/ml_NN bovine_JJ serum_NN albumin_NN (_( BSA_NP )_) were_VBD incubated_VBN with_IN metabolic_JJ inhibitors_NNS (_( 0.6_CD mM_NP 2-deoxyglucose_JJ and_CC 10_CD muM_NN antimycin_NP A_NP )_) for_IN 5_CD min_NN at_IN 37C_JJ and_CC then_RB cooled_VBN to_TO ice_VB temperature_NN and_CC added_VBD to_TO SLO_NP (_( 1.6_CD IU/ml_NN )_) in_IN the_DT presence_NN of_IN 0.1_CD mM_NP EGTA_NP ._SENT After_IN 5_CD min_NN ,_, cells_NNS were_VBD washed_VBN free_JJ of_IN unbound_JJ SLO_NP and_CC contaminating_VBG impurities_NNS by_IN dilution_NN and_CC centrifugation_NN at_IN 4C_JJ ._SENT Permeabilization_NP and_CC hence_RB rundown_JJ of_IN the_DT secretory_JJ response_NN was_VBD initiated_VBN by_IN transferring_VBG the_DT cells_NNS to_TO prewarmed_JJ (_( 37C_JJ )_) assay_NN buffer_NN containing_VBG 1_CD mg/ml_NN BSA_NP ,_, 0.3_CD mM_NP Ca/EGTA_NP buffer_NN (_( 10_CD nM_NP Ca2+_NP )_) ,_, 100_CD muM_NN MgATP_NN ,_, and_CC proteins_NNS under_IN test_NN in_IN 96-well_NN microtiter_NN plates_NNS ._SENT After_IN allowing_VBG predetermined_VBN times_NNS for_IN rundown_NN (_( generally_RB between_IN 5_CD and_CC 20_CD min_NN )_) ,_, the_DT cells_NNS were_VBD stimulated_VBN to_TO secrete_VB by_IN addition_NN of_IN solutions_NNS containing_VBG Ca/EGTA_NP buffers_NNS formulated_VBD to_TO regulate_VB 10_CD muM_NN Ca2+(or_NP 100_CD nM_NN Ca2+_NN for_IN controls_NNS )_) to_TO a_DT final_JJ concentration_NN of_IN 3_CD mM_NP and_CC GTP-gamma-S_NP to_TO a_DT final_JJ concentration_NN of_IN 100_CD muM_NN (_( or_CC zero_NN for_IN controls_NNS )_) with_IN sufficient_JJ MgATP_NP to_TO maintain_VB the_DT concentration_NN at_IN 100_CD muM_NN ._SENT After_IN 20_CD min_NN the_DT reactions_NNS were_VBD quenched_VBN by_IN addition_NN of_IN ice-cold_JJ buffer_NN supplemented_VBN with_IN EGTA_NP (_( 10_CD mM_NNS )_) ,_, and_CC the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ._SENT The_DT supernatants_NNS were_VBD sampled_VBN for_IN measurement_NN of_IN secreted_VBN hexosaminidase_NN as_IN previously_RB described_VBN ._SENT Calcium/EGTA_NP buffers_NNS were_VBD prepared_VBN by_IN mixing_VBG solutions_NNS of_IN EGTA_NP and_CC end-point_NN --_: titrated_VBD CaEGTA_NP made_VBD up_RP at_IN identical_JJ concentrations_NNS and_CC adjusted_VBN to_TO pH_NN 6.8_CD ,_, according_VBG to_TO a_DT computer_NN program_NN ,_, as_RB previously_RB described_VBN ._SENT Secretion_NN is_VBZ expressed_VBN as_IN the_DT percent_NN of_IN total_JJ cellular_JJ hexosaminidase_NN released_VBN ,_, calibrated_VBN by_IN reference_NN to_TO appropriate_JJ reagent_NN blanks_NNS and_CC the_DT total_JJ cell_NN content_NN released_VBN by_IN 0.1_CD %_NN Triton_NP X-100_NP ._SENT Stimulated_VBN secretion_NN is_VBZ calculated_VBN as_IN the_DT difference_NN in_IN the_DT amount_NN of_IN hexosaminidase_NN released_VBN in_IN response_NN to_TO 100_CD nM_NN Ca2+_NP or_CC 10_CD muM_NP Ca2+_NP +_SYM 100_CD muM_NN GTPgammaS_NNS ._SENT All_DT determinations_NNS were_VBD carried_VBN out_RP in_IN quadruplicate_NN unless_IN otherwise_RB stated_VBN ._SENT Purification_NN of_IN Secernin_NP 1_CD ._SENT |_SYM All_DT chromatography_NN was_VBD carried_VBN out_RP on_IN a_DT Biologic_JJ liquid_JJ chromatography_NN system_NN at_IN 4C_JJ ._SENT Frozen_VBN bovine_JJ brains_NNS ,_, 500_CD g_NN ,_, were_VBD thawed_VBN at_IN 4C_JJ before_IN homogenization_NN in_IN a_DT Waring_NP blender_NN in_IN 1_CD liter_NN homogenization_NN buffer_NN (_( 137_CD mM_NP NaCl_NP ,_, 2.3_CD mM_NP KCl_NP ,_, 1_CD mM_NP MgCl2_NP ,_, 1_CD mM_NP EGTA_NP ,_, 1_CD muM_NN Pepstatin_NP ,_, 1_CD muM_NN Leupeptin_NP ,_, 0.1_CD mM_NP PMSF_NP ,_, 0.02_CD %_NN NaN3_NP ,_, 20_CD mM_NP Pipes_NP ,_, pH_NN 6.8_CD )_) ._SENT The_DT homogenate_NN was_VBD then_RB centrifuged_VBN for_IN 10_CD h_NN at_IN 10,000_CD x_NN g_NN at_IN 4C_JJ in_IN a_DT fixed_VBN angle_NN rotor_NN ._SENT This_DT cytosol_NN extract_NN was_VBD subjected_VBN to_TO ammonium_NN sulfate_NN precipitation_NN and_CC an_DT active_JJ fraction_NN between_IN 60_CD and_CC 90_CD %_NN (NH4)2SO4_NN was_VBD resuspended_VBN in_IN 40_CD ml_NN homogenization_NN buffer_NN ._SENT The_DT active_JJ material_NN was_VBD subjected_VBN to_TO chromatography_NN on_IN Octyl_NP Sepharose_NP FF_NP as_IN previously_RB described_VBN ,_, and_CC the_DT active_JJ fractions_NNS were_VBD combined_VBN ._SENT All_DT column_NN fractions_NNS under_IN test_NN were_VBD buffer_NN exchanged_VBN into_IN assay_NN buffer_NN using_VBG NAP-5_NP columns_NNS before_IN assay_NN ._SENT DEAE_NP Chromatography_NP ._SENT |_SYM The_DT active_JJ fractions_NNS from_IN the_DT Octyl_NP Sepharose_NP column_NN were_VBD combined_VBN and_CC desalted_VBN into_IN buffer_NN A_NP (_( 20_CD mM_NP diethanolamine_NN ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 8.7_CD )_) in_IN aliquots_NNS of_IN 5_CD ml_NN on_IN a_DT HiPrep_NP 26/10_CD desalting_VBG column_NN (_( Pharmacia_NP )_) ._SENT The_DT desalted_VBN material_NN was_VBD loaded_VBN ,_, using_VBG on_IN line_NN dilution_NN via_IN the_DT pump_NN ,_, at_IN 20_CD %_NN protein_NN with_IN 80_CD %_NN buffer_NN A_NP ,_, onto_IN a_DT DEAE_NP Sepharose_NP column_NN (_( XK26/50_NP ,_, 100_CD ml_NN ,_, Pharmacia_NP )_) that_WDT had_VBD been_VBN equilibrated_VBN with_IN buffer_NN A._NP The_DT column_NN was_VBD then_RB washed_VBN with_IN 36_CD ml_NN 20_CD mM_NP diethanolamine_NN ,_, pH_NN 8.7_CD ,_, before_IN elution_NN with_IN a_DT linear_JJ gradient_NN of_IN 0_CD --_: 40_CD %_NN buffer_NN B_NP (_( 1_CD M_NP NaCl_NP ,_, 20_CD mM_NP diethanolamine_NN ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 8.7_CD )_) over_IN 372_CD ml_NN followed_VBN by_IN a_DT final_JJ elution_NN in_IN 100_CD %_NN buffer_NN B_NN over_IN 120_CD ml_NN ._SENT The_DT column_NN was_VBD run_VBN at_IN 5_CD ml/min_NN ,_, and_CC 8-ml_JJ fractions_NNS were_VBD collected_VBN ._SENT The_DT fractions_NNS were_VBD assayed_VBN for_IN activity_NN ,_, and_CC the_DT active_JJ fractions_NNS (_( 45_CD --_: 52_CD )_) on_IN the_DT third_JJ peak_NN were_VBD combined_VBN ._SENT Hydroxyapatite_NP Chromatography_NP ._SENT |_SYM Active_JJ fractions_NNS (_( 45_CD --_: 52_CD )_) from_IN the_DT third_JJ peak_NN of_IN the_DT DEAE_NP chromatography_NN were_VBD concentrated_VBN to_TO 5_CD ml_NN on_IN a_DT 50-ml_JJ Amicon_NP pressure_NN concentrator_NN (_( 43-mm_NP YM10_NP membrane_NN )_) and_CC then_RB desalted_VBN into_IN buffer_NN C_NP (_( 50_CD mM_NP MES_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 6.0_CD )_) on_IN a_DT HiPrep_NP 26/10_CD desalting_VBG column_NN ._SENT This_DT was_VBD then_RB loaded_VBN onto_IN a_DT ceramic_JJ hydroxyapatite_NN column_NN (_( Econo-Pac_NP CHT-II_NP ,_, 1_CD ml_NN ,_, )_) preequilibrated_JJ with_IN buffer_NN C._NP The_DT column_NN was_VBD then_RB washed_VBN with_IN 2_CD ml_NN buffer_NN C_NP before_IN elution_NN with_IN a_DT linear_JJ gradient_NN of_IN 0_CD --_: 100_CD %_NN buffer_NN D_NP (_( 500_CD mM_NP NaCl_NP ,_, 50_CD mM_NP MES_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 6.0_CD )_) over_IN 16_CD ml_NN ._SENT The_DT column_NN was_VBD then_RB washed_VBN with_IN an_DT additional_JJ 2_CD ml_NN buffer_NN D_NP ,_, before_IN elution_NN with_IN a_DT 0_CD --_: 100_CD %_NN linear_JJ gradient_NN of_IN buffer_NN E_NN (_( 500_CD mM_NP KH2PO4_NP ,_, 50_CD mM_NP MES_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 6.0_CD )_) over_IN 16_CD ml_NN and_CC finally_RB washed_VBN with_IN an_DT additional_JJ 4_CD ml_NN of_IN buffer_NN E._NP The_DT column_NN was_VBD run_VBN at_IN 1_CD ml/min_NN ,_, and_CC 1-ml_JJ fractions_NNS were_VBD collected_VBN ._SENT The_DT fractions_NNS were_VBD assayed_VBN for_IN activity_NN ,_, and_CC the_DT active_JJ fractions_NNS (_( 35_CD --_: 38_CD )_) in_IN the_DT second_JJ peak_NN were_VBD combined_VBN ._SENT Phenyl_NN Superose_NP Chromatography_NP ._SENT |_SYM The_DT combined_JJ fractions_NNS from_IN peak_NN 2_CD of_IN the_DT hydroxyapatite_NN column_NN were_VBD diluted_VBN with_IN 3.4_CD M_NN (NH4)2SO4_NN ,_, buffered_VBN with_IN 50_CD mM_NP NaH2PO4_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 7.5_CD ,_, to_TO produce_VB a_DT final_JJ concentration_NN of_IN 2_CD M_NN (NH4)2SO4_NN ._SENT The_DT protein_NN was_VBD then_RB applied_VBN to_TO a_DT Phenyl_NP Superose_NP column_NN (_( Pharmacia_NP ,_, HR5/5_NP ,_, 1_CD ml_NN )_) equilibrated_VBN in_IN buffer_NN F_NN ((NH4)2SO4_NN ,_, 50_CD mM_NP NaH2PO4_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 7.5_CD )_) and_CC the_DT column_NN washed_VBN with_IN 5_CD ml_NN 100_CD %_NN buffer_NN F_NN before_IN eluting_VBG with_IN a_DT 30_CD --_: 80_CD %_NN gradient_NN of_IN buffer_NN G_NP (_( 50_CD mM_NP NaH2PO4_NP ,_, 0.02_CD %_NN NaN3_NP ,_, pH_NN 7.5_CD )_) over_IN 30_CD ml_NN ,_, followed_VBN by_IN a_DT final_JJ 5_CD ml_NN of_IN 100_CD %_NN buffer_NN G._NP The_DT column_NN was_VBD run_VBN at_IN 0.4_CD ml/min_NN ,_, and_CC 1-ml_JJ fractions_NNS were_VBD collected_VBN ._SENT Superose_NP 12_CD Chromatography_NN ._SENT |_SYM Active_JJ fractions_NNS from_IN the_DT Phenyl_NP Superose_NP (_( 21_NP --_: 23_LS )_) were_VBD concentrated_VBN to_TO 240_CD mul_NN on_IN a_DT 10K_NP Microsep_NP centrifugal_JJ concentrator_NN (_( Filtron_NP ,_, Northborough_NP ,_, MA_NP )_) at_IN 4C_JJ and_CC injected_VBN onto_IN a_DT Superose_NP 12_CD column_NN (_( Pharmacia_NP ,_, HR10/30_NP ,_, 24_CD ml_NN )_) equilibrated_VBN in_IN homogenization_NN buffer_NN ._SENT The_DT column_NN was_VBD run_VBN at_IN 0.2/ml_NN min_NN ,_, and_CC 0.5-ml_NN fractions_NNS were_VBD collected_VBN ._SENT The_DT active_JJ fractions_NNS were_VBD combined_VBN and_CC concentrated_VBN before_IN use_NN in_IN secretion_NN experiments_NNS ._SENT Leakage_NN of_IN Secernin_NP ._SENT |_SYM Purified_JJ mast_NN cells_NNS were_VBD treated_VBN with_IN diisopropyl_NN fluorophosphate_NN (_( 2_CD mM_NNS )_) for_IN 10_CD min_NN at_IN 4C_JJ ._SENT The_DT cells_NNS were_VBD treated_VBN with_IN SLO_NP at_IN ice_NN temperature_NN as_RB described_VBD above_JJ ,_, resuspended_JJ at_IN similar1_NP x_SYM 106cells/ml_JJ ,_, and_CC then_RB permeabilized_VBN by_IN bringing_VBG the_DT temperature_NN to_TO 37C_JJ ._SENT Samples_NNS of_IN cells_NNS ,_, 100_CD mul_NN ,_, were_VBD removed_VBN at_IN intervals_NNS and_CC sedimented_JJ by_IN centrifugation_NN at_IN 14,000_CD x_NN g_NN ,_, and_CC the_DT supernatants_NNS were_VBD harvested_VBN ._SENT Ice-cold_JJ acetone_NN was_VBD added_VBN to_TO the_DT supernatants_NNS to_TO a_DT final_JJ concentration_NN of_IN 80_CD %_NN ,_, and_CC the_DT mixture_NN was_VBD maintained_VBN at_IN -20C_NN for_IN 2_CD h_NN after_IN which_WDT the_DT aggregated_VBN proteins_NNS were_VBD sedimented_VBN by_IN centrifugation_NN at_IN 14,000_CD x_SYM g._FW These_DT were_VBD taken_VBN up_RP in_IN Laemmli_NP sample_NN buffer_NN and_CC separated_VBN on_IN 12_CD %_NN SDS-polyacrylamide_NN gels_NNS ._SENT Proteins_NNS were_VBD transferred_VBN to_TO nitrocellulose_NN using_VBG a_DT wet_JJ blot_NN method_NN and_CC probed_VBN for_IN Secernin_NP using_VBG the_DT polyclonal_JJ anti-Secernin_NN antibodies_NNS ,_, SK1147_NP and_CC SK1148_NP ,_, at_IN a_DT dilution_NN of_IN 1:4000_CD ._SENT Antibody_NN binding_NN was_VBD detected_VBN using_VBG a_DT donkey_NN anti-rabbit_NN HRP-linked_JJ secondary_JJ antibody_NN at_IN 1:2000_CD dilution_NN and_CC an_DT ECL_NP detection_NN kit_NN ._SENT Plasmid_NP Construction_NP ._SENT |_SYM Oligonucleotide_NN primers_NNS for_IN the_DT amplification_NN of_IN the_DT KIAA0193_NP gene_NN were_VBD designed_VBN with_IN attB1_JJ or_CC attB2_JJ sites_NNS for_IN the_DT insertion_NN into_IN the_DT GATEWAY_NP donor_NN vector_NN pDONR201_NN (_( Life_NP Technologies_NPS )_) by_IN homologous_JJ recombination_NN ._SENT Primers_NNS with_IN the_DT following_VBG sequences_NNS were_VBD synthesized_VBN by_IN MWG_NP ,_, Inc._NP :_: KIAA0193_NP (_( forward_RB )_) ,_, 5'-_NP GGGGACAAGTTTGTACAAAAAAGCAGGCTTCG_NP A_NP A_NP GGAGATAGAACCATGATAAGCAGACCCGCCTGGCTCT-3_NP '_'' ;_: KIAA_NP 0193_CD (_( reverse_NN )_) ,_, 5'-GGGGACCACTTTGTACAAGAAAGCTGGGTC-CTATCACTTAAAGAACTTAATCTCCGTG-3_NP '_POS ._SENT The_DT primers_NNS were_VBD used_VBN to_TO generate_VB the_DT attB_JJ PCR_NP product_NN using_VBG a_DT ThermalAce_NP DNA_NP polymerase_NN kit_NN (_( Invitrogen_NP )_) from_IN the_DT pBluescript_JJ SK+_NP vector_NN containing_VBG KIAA0193_NP ._SENT The_DT PCR_NP products_NNS were_VBD cloned_VBN into_IN pDONR201_JJ ,_, and_CC the_DT resulting_VBG plasmid_NP pENTR_NP KIAA0193_NP were_VBD used_VBN to_TO transfer_VB the_DT gene_NN sequences_NNS into_IN pDEST15_NN (_( N_NP terminal_JJ GST_JJ fusion_NN )_) or_CC pDEST17_JJ (_( N_NP terminal_NN His_PP$ fusion_NN )_) via_IN homologous_JJ recombination_NN ._SENT The_DT corresponding_JJ plasmids_NNS ,_, pEXP15_NP KIAA0193_NP and_CC pEXP17_JJ KIAA0193_NP ,_, were_VBD used_VBN for_IN overexpression_NN of_IN the_DT fusion_NN proteins_NNS in_IN Escherichia_NP coli_NNS BL21-SI_NP ._SENT Recombinant_JJ Protein_NP Purification_NP ._SENT |_SYM Cells_NP carrying_VBG either_DT pEXP15_JJ KIAA0193_NP or_CC pEXP17_JJ KIAA0193_NP were_VBD grown_VBN overnight_RB in_IN LB_NP broth_NN without_IN NaCl_NP in_IN the_DT presence_NN of_IN 100_CD mug/ml_NN ampicillin_NN at_IN 30C_JJ ._SENT The_DT cells_NNS were_VBD then_RB diluted_VBN 1_CD in_IN 10_CD in_IN prewarmed_JJ LB_NP broth_NN without_IN NaCl_NP ,_, in_IN the_DT presence_NN of_IN 100_CD mug/ml_NN ampicillin_NN at_IN 30C_JJ ,_, and_CC grown_VBN to_TO an_DT optical_JJ density_NN of_IN 0.6_CD at_IN 600_CD nm_NN ._SENT Protein_NN expression_NN was_VBD induced_VBN by_IN the_DT addition_NN of_IN NaCl_NP to_TO 0.3_CD M_NN ,_, and_CC the_DT cells_NNS were_VBD grown_VBN for_IN a_DT further_JJR 3_CD h._NP Cells_NP were_VBD harvested_VBN by_IN centrifugation_NN ,_, and_CC inclusion_NN bodies_NNS were_VBD purified_VBN by_IN the_DT method_NN of_IN ._SENT Affinity_NN Purification_NN of_IN Antibody_NN SK1147_JJ ._SENT |_SYM Inclusion_NN bodies_NNS of_IN the_DT recombinant_JJ GST-tagged_JJ KIAA_NP 0193_CD (_( human_NN Secernin_NP 1_CD )_) were_VBD solubilized_VBN in_IN SDS-sample_NP buffer_NN and_CC separated_VBN on_IN 10_CD %_NN SDS-PAGE_NN ._SENT After_IN blotting_VBG onto_IN nitrocellulose_NN paper_NN the_DT recombinant_JJ protein_NN was_VBD visualized_VBN with_IN Ponceau_NP S_NP staining_VBG ,_, and_CC the_DT bands_NNS were_VBD excised_VBN ._SENT The_DT antibody_NN SK1148_NP was_VBD affinity_NN purified_VBN against_IN this_DT protein_NN by_IN the_DT method_NN of_IN ._SENT The_DT antibody_NN was_VBD dialyzed_VBN overnight_RB against_IN homogenization_NN buffer_NN before_IN use_NN in_IN neutralization_NN experiments_NNS ._SENT Immunoneutralization_NN of_IN Secernin_NP ._SENT |_SYM Polyclonal_NP anti-Secernin_NP antibody_NN SK1147_JJ or_CC preimmune_JJ serum_NN was_VBD diluted_VBN 1:50_CD into_IN assay_NN buffer_NN and_CC added_VBD an_DT equal_JJ volume_NN of_IN either_DT purified_VBN 60_CD mug/ml_NN Secernin_NN or_CC 6_CD mg/ml_NN freshly_RB prepared_VBN rat_NN brain_NN cytosol_NN in_IN assay_NN buffer_NN ._SENT The_DT antibody_NN and_CC proteins_NNS were_VBD incubated_VBN at_IN 4C_JJ for_IN 30_CD min_NN before_IN addition_NN to_TO permeabilized_JJ mast_NN cells_NNS at_IN a_DT final_JJ concentration_NN of_IN 10_CD mug/ml_NN Secernin_NN and_CC 1_CD mg/ml_NN cytosol_NN as_RB described_VBD above_IN ._SENT Varying_VBG concentrations_NNS of_IN affinity-purified_JJ SK1147_JJ was_VBD incubated_VBN with_IN 3_CD mg/ml_NN cytosol_NN in_IN the_DT presence_NN or_CC absence_NN of_IN 5_CD mg/ml_NN inclusion_NN body_NN containing_VBG recombinant_JJ human_JJ Secernin_NP 1-His_NP fusion_NN protein_NN ._SENT After_IN incubation_NN for_IN 60_CD min_NN at_IN 4C_NP ,_, the_DT cytosol_NN was_VBD centrifuged_VBN at_IN 14,000_CD x_NN g_NN to_TO remove_VB the_DT inclusion_NN body_NN before_IN addition_NN to_TO permeabilized_JJ mast_NN cells_NNS at_IN a_DT final_JJ concentration_NN of_IN 1_CD mg/ml_NN cytosol_NN and_CC antibody_NN as_RB indicated_VBD ._SENT Protein_NN Assay_NP ._SENT |_SYM Protein_NP concentration_NN was_VBD assayed_VBN by_IN the_DT method_NN of_IN using_VBG BSA_NP as_IN a_DT standard_NN ._SENT Protein_NN Analysis_NN ._SENT |_SYM Purity_NN of_IN protein_NN samples_NNS was_VBD assessed_VBN by_IN electrophoretic_JJ separation_NN on_IN 12_CD %_NN SDS-polyacrylamide_NN gels_NNS and_CC detection_NN by_IN silver_NN staining_VBG ._SENT Production_NN of_IN Antisera_NN ._SENT |_SYM Two_NP polyclonal_JJ rabbit_NN antisera_NP (_( SK1147_NP and_CC SK1148_NP )_) were_VBD raised_VBN against_IN purified_VBN Secernin_NP 1_CD by_IN Abcam_NP Ltd._NP (_( Cambridge_NP ,_, UK_NP )_) ,_, using_VBG a_DT 30-mug_JJ initial_JJ injection_NN followed_VBN by_IN three_CD booster_NN injections_NNS of_IN 30_CD mug_NN ._SENT Mass_NP Spectrometric_NP Analysis_NP ._SENT |_SYM p50_NN was_VBD alkylated_VBN with_IN iodoacetamide_NN in_IN sample_NN buffer_NN (_( Novex_NP ,_, Encinitas_NP ,_, CA_NP )_) and_CC run_VB on_IN a_DT 4_CD --_: 12_CD %_NN SDS-PAGE_NN gel_NN with_IN a_DT MOPS_NP running_VBG buffer_NN system_NN (_( Novex_NP )_) ._SENT The_DT gel_NN was_VBD stained_VBN with_IN Sypro_NP Orange_NP (_( Molecular_NP Probes_NP ,_, Eugene_NP ,_, OR_NP )_) ,_, and_CC the_DT p50_JJ band_NN was_VBD excised_VBN and_CC digested_VBN with_IN 12.5_CD mug/ml_NN modified_JJ trypsin_NN (_( Roche_NP )_) in_IN 20_CD mM_NP NH4CO3_NP ._SENT A_DT proportion_NN of_IN the_DT sample_NN was_VBD analyzed_VBN by_IN MALDI-TOF_NP MS_NP ,_, and_CC the_DT tryptic_JJ peptide_NN ions_NNS were_VBD searched_VBN against_IN NCBI_NP and_CC Swiss_NP Prot_NP databases_NNS using_VBG the_DT MS-FIT_NP search_NN algorithm_NN from_IN Protein_NP Prospector_NP (_( UCSF_NP ,_, San_NP Francisco_NP ,_, CA_NP )_) ._SENT The_DT remainder_NN of_IN the_DT sample_NN was_VBD chromatographed_VBN on_IN a_DT 150_CD x_NN 0.075-mm_NP Pepmap_NP C18_NP capillary_JJ column_NN coupled_VBN to_TO an_DT LC_NP Packings_NP Ultima_NP HPLC_NP system_NN (_( Dionex_NP ,_, Camberley_NP ,_, UK_NP )_) ._SENT The_DT column_NN was_VBD equilibrated_VBN with_IN 2_CD %_NN acetonitrile/0.1_JJ %_NN formic_JJ acid_NN in_IN water_NN at_IN 0.2_CD mul/min_NN ,_, and_CC developed_VBN with_IN a_DT gradient_NN of_IN acetonitrile/0.1_JJ %_NN formic_JJ acid_NN ._SENT The_DT outlet_NN of_IN the_DT column_NN was_VBD connected_VBN to_TO a_DT Micromass_NP Q-TOF2_NP mass_NN spectrometer_NN ,_, equipped_VBN with_IN a_DT nanoflow_NN source_NN ,_, and_CC peptide_NN ions_NNS were_VBD automatically_RB submitted_VBN for_IN ms/ms_NNS fragmentation_NN ._SENT Spectra_NN from_IN ms/ms_NNS experiments_NNS were_VBD interpreted_VBN ,_, and_CC the_DT sequences_NNS were_VBD searched_VBN against_IN NCBI_NP nr_NN and_CC dbEST_NN databases_NNS using_VBG the_DT BLAST_NP search_NN algorithm_NN ._SENT Spectral_JJ data_NNS was_VBD also_RB searched_VBN against_IN the_DT same_JJ databases_NNS using_VBG the_DT Sonar_NP ms/ms_NNS search_NN algorithm_NN ._SENT Bovine_JJ brain_NN cytosol_NN was_VBD prepared_VBN and_CC fractionated_VBN by_IN ammonium_NN sulfate_NN precipitation_NN followed_VBN by_IN Octyl_NP Sepharose_NP chromatography_NN as_IN previously_RB described_VBN ._SENT The_DT purification_NN of_IN Secernin_NP 1_CD described_VBD in_IN MATERIALS_NP AND_CC METHODS_NP is_VBZ summarized_VBN in_IN Table_NP ._SENT Activity_NN from_IN cytosol_NN prepared_VBN from_IN frozen_JJ bovine_JJ brains_NNS is_VBZ only_RB detectable_JJ after_IN the_DT Octyl_NP Sepharose_NP column_NN ,_, unlike_IN cytosol_NN from_IN freshly_RB isolated_VBN rat_NN brains_NNS ._SENT The_DT purification_NN is_VBZ therefore_RB calculated_VBN from_IN the_DT pooled_JJ activity_NN from_IN this_DT column_NN ._SENT Figure_NP A_NP shows_VBZ that_IN the_DT activity_NN eluted_VBN from_IN the_DT Octyl_NP Sepharose_NP can_MD be_VB separated_VBN by_IN a_DT DEAE_NP Sepharose_NP column_NN into_IN three_CD distinct_JJ peaks_NNS of_IN activity_NN by_IN a_DT gradient_NN of_IN NaCl_NP ._SENT Peak_NN 1_CD was_VBD found_VBN to_TO contain_VB the_DT previously_RB purified_VBN rac_NN and_CC rhoGDI_NN ,_, as_RB assessed_VBN by_IN Western_JJ blotting_VBG ,_, so_RB further_JJR purification_NN of_IN this_DT peak_NN was_VBD not_RB undertaken_VBN ._SENT Peak_NP 3_CD appeared_VBD to_TO have_VB the_DT highest_JJS activity_NN and_CC was_VBD therefore_RB subjected_VBN to_TO further_JJR purification_NN ._SENT Table_NP 1_CD |_SYM Purification_NN of_IN secernin_NP 1_CD Figure_NP 1_CD |_SYM Purification_NN of_IN secernin_NN ._SENT Purification_NN of_IN secernin_NN ._SENT (_( A_NP )_) DEAE_NP chromatography_NN ._SENT Active_JJ fractions_NNS from_IN Octyl_NP Sepharose_NP were_VBD desalted_VBN and_CC loaded_VBN onto_IN a_DT DEAE_NP Sepharose_NP column_NN ,_, the_DT activity_NN was_VBD eluted_VBN with_IN a_DT rising_VBG gradient_NN of_IN NaCl_NP ._SENT (_( B_NP )_) Hydroxyapatite_NP chromatography_NN ._SENT Pooled_JJ fractions_NNS from_IN peak_NN 3_CD on_IN the_DT DEAE_NP column_NN were_VBD desalted_VBN and_CC applied_VBN to_TO a_DT ceramic_JJ hydroxyapatite_NN column_NN ._SENT The_DT activity_NN was_VBD initially_RB eluted_VBN with_IN a_DT rising_VBG gradient_NN of_IN NaCl_NP followed_VBD by_IN a_DT second_JJ gradient_NN of_IN KH2PO4_NP ._SENT (_( C_NP )_) Phenyl_NP Superose_NP chromatography_NN ._SENT Pooled_JJ fractions_NNS from_IN peak_NN 2_CD on_IN the_DT hydroxyapatite_NN column_NN were_VBD adjusted_VBN to_TO 2_CD M_NN (NH4)2SO4_NN and_CC applied_VBD to_TO a_DT Phenyl_NP Superose_NP column_NN ._SENT The_DT activity_NN was_VBD eluted_VBN with_IN a_DT falling_VBG gradient_NN of_IN (NH4)2SO4_NN ._SENT All_DT column_NN activities_NNS were_VBD assayed_VBN for_IN protein_NN concentration_NN and_CC stimulated_VBN secretion_NN as_IN described_VBN in_IN the_DT MATERIALS_NP AND_CC METHODS_NP ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN at_IN least_JJS 10_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT The_DT combined_JJ fractions_NNS of_IN peak_NN 3_CD from_IN the_DT DEAE_NP column_NN were_VBD applied_VBN to_TO a_DT hydroxyapatite_NN column_NN and_CC eluted_VBN with_IN a_DT rising_VBG gradient_NN of_IN NaCl_NP ,_, followed_VBN by_IN a_DT rising_VBG gradient_NN of_IN KH2PO4_NP as_IN shown_VBN in_IN Figure_NP B._NP A_DT small_JJ peak_NN of_IN activity_NN elutes_VBZ with_IN NaCl_NP and_CC a_DT larger_JJR second_JJ activity_NN elutes_VBZ with_IN KH2PO4_NP ._SENT This_DT second_JJ activity_NN peak_NN was_VBD pooled_VBN ,_, applied_VBN to_TO a_DT Phenyl_NP Superose_NP column_NN and_CC eluted_VBN by_IN a_DT decreasing_VBG gradient_NN of_IN (NH4)2SO4_NN as_IN shown_VBN in_IN Figure_NP C._NP Fractions_NNS from_IN the_DT column_NN were_VBD then_RB subjected_VBN to_TO SDS-PAGE_NP analysis_NN ,_, a_DT single_JJ protein_NN of_IN 50_CD kDa_NN appears_VBZ to_TO correlate_VB with_IN the_DT activity_NN from_IN the_DT phenyl_NN superose_NN column_NN ._SENT To_TO confirm_VB the_DT correlation_NN ,_, the_DT pooled_JJ fractions_NNS from_IN the_DT Phenyl_NP Superose_NP column_NN were_VBD concentrated_VBN and_CC applied_VBN to_TO a_DT Superose_NP 12_CD gel_NN filtration_NN column_NN ._SENT The_DT fractions_NNS were_VBD assayed_VBN for_IN their_PP$ ability_NN to_TO retard_VB the_DT rundown_NN of_IN exocytosis_NN in_IN mast_NN cells_NNS and_CC subjected_VBN to_TO SDS-PAGE_NP ,_, and_CC again_RB a_DT single_JJ 50-kDa_NP protein_NN was_VBD found_VBN to_TO correlate_VB with_IN the_DT activity_NN ,_, as_RB shown_VBN in_IN Figure_NP ._SENT Figure_NP 2_CD |_SYM Superose_NP 12_CD chromatography_NN ._SENT Superose_NP 12_CD chromatography_NN ._SENT (_( A_NP )_) Active_JJ fractions_NNS from_IN the_DT Phenyl_NP Superose_NP column_NN were_VBD concentrated_VBN and_CC loaded_VBN onto_IN a_DT superose_JJ 12_CD gel_NN filtration_NN column_NN and_CC assayed_VBN for_IN protein_NN concentration_NN and_CC stimulated_VBN secretion_NN as_IN described_VBN in_IN the_DT MATERIALS_NP AND_CC METHODS_NP ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN at_IN least_JJS 10_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT (_( B_LS )_) Active_JJ fractions_NNS were_VBD analyzed_VBN by_IN silver-stained_JJ 12_CD %_NN SDS-PAGE_NN ._SENT To_TO identify_VB the_DT 50-kDa_NP protein_NN ,_, the_DT purified_VBN material_NN was_VBD subjected_VBN to_TO SDS-PAGE_NN and_CC in-gel_NN trypsinization_NN ._SENT The_DT peptide_NN mixture_NN was_VBD recovered_VBN and_CC subjected_VBN to_TO MALDI-TOF_NP mass_NN spectrometry_NN ,_, and_CC the_DT resultant_JJ mass_NN fingerprint_NN used_VBN to_TO interrogate_VB sequence_NN databases_NNS ._SENT This_DT analysis_NN identified_VBD p50_NN as_IN a_DT protein_NN corresponding_JJ to_TO a_DT previously_RB cloned_VBN mouse_NN cDNA_NN (_( GenBank_NP accession_NN no_RB ._SENT )_) of_IN unknown_JJ function_NN ._SENT To_TO confirm_VB the_DT identity_NN of_IN p50_NN ,_, the_DT balance_NN of_IN the_DT peptide_NN mixture_NN was_VBD chromatographed_VBN by_IN reverse-phase_NP HPLC_NP ,_, and_CC individual_JJ peptides_NNS were_VBD delivered_VBN to_TO an_DT online_JJ Q-TOF_NP mass_NN spectrometer_NN for_IN ms/ms_NNS fragmentation_NN and_CC consequent_JJ peptide_NN sequence_NN identification_NN ._SENT A_DT total_NN of_IN seven_CD peptides_NNS were_VBD sequenced_JJ (_( Figure_NP B_NP ,_, bold_JJ )_) ._SENT Of_IN these_DT ,_, three_CD corresponded_VBD to_TO peptides_NNS previously_RB identified_VBN by_IN mass_JJ fingerprint_NN ,_, and_CC each_DT showed_VBN sequence_NN identity_NN with_IN the_DT putative_JJ protein_NN encoded_VBN by_IN ._SENT One_CD peptide_NN ,_, not_RB identified_VBN in_IN the_DT initial_JJ mass_NN fingerprint_NN also_RB was_VBD identical_JJ to_TO the_DT mouse_NN sequence_NN ,_, whereas_IN three_CD additional_JJ peptides_NNS were_VBD closely_RB related_VBN ,_, showing_VBG >75_JJ %_NN homology_NN with_IN it_PP ._SENT We_PP conclude_VBP that_IN p50_NN is_VBZ a_DT novel_JJ protein_NN ,_, which_WDT we_PP have_VBP named_VBN Secernin_NP 1_CD ,_, which_WDT is_VBZ encoded_VBN by_IN the_DT bovine_JJ orthologue_NN of_IN mouse_NN ._SENT Figure_NP 3_CD |_SYM Identification_NN of_IN p50_NN by_IN MALDI-TOF_NP and_CC Q-TOF_NP mass_NN spectrometry_NN ._SENT Identification_NN of_IN p50_NN by_IN MALDI-TOF_NP and_CC Q-TOF_NP mass_NN spectrometry_NN ._SENT A_DT tryptic_JJ digest_NN of_IN p50_NN excised_VBN from_IN a_DT SDS-PAGE_NP gel_NN was_VBD subjected_VBN either_RB to_TO fingerprint_VB analysis_NN by_IN MALDI-TOF_NP mass_JJ spectrometry_NN or_CC reverse-phase_NN HPLC_NN and_CC online_JJ Q-TOF_NP ms/ms_NNS fragmentation_NN ._SENT (_( A_NP )_) MALDI-TOF_NP mass_NN spectrum_NN annotated_VBN with_IN the_DT sequence_NN and_CC molecular_JJ mass_NN (_( m/z_NN )_) of_IN identified_VBN peptides_NNS (_( highlighted_VBN in_IN gray_JJ )_) ._SENT Peptides_NNS whose_WP$ sequence_NN was_VBD deduced_VBN by_IN Q-TOF_NP fragmentation_NN analysis_NN are_VBP boxed_VBN ._SENT (_( B_LS )_) The_DT predicted_VBN polypeptide_NN sequence_NN encoded_VBN by_IN mouse_NN cDNA_NN ._SENT Peptide_NN sequences_NNS identified_VBN by_IN MALDI_NP fingerprint_NN analysis_NN above_IN are_VBP highlighted_VBN in_IN gray_JJ ._SENT Peptides_NNS whose_WP$ sequence_NN was_VBD deduced_VBN by_IN MS/MS_NP fragmentation_NN (_( in_IN bold_JJ font_NN )_) are_VBP aligned_VBN ._SENT ||_NN indicates_VBZ a_DT match_NN ,_, +_SYM indicates_VBZ a_DT conserved_VBN substitution_NN ,_, and_CC (_( ._SENT )_) indicates_VBZ a_DT mismatch_NN between_IN the_DT sequences_NNS ._SENT The_DT outlined_VBN area_NN represents_VBZ the_DT predicted_VBN coiled-coil_NN region_NN ._SENT Figure_NN shows_VBZ the_DT effect_NN of_IN increasing_VBG concentrations_NNS of_IN purified_VBN Secernin_NP 1_CD on_IN the_DT secretion_NN of_IN hexosaminidase_NN from_IN permeabilized_JJ mast_NN cells_NNS ._SENT The_DT optimal_JJ concentration_NN of_IN Secernin_NP 1_CD is_VBZ 7.1_CD +-_NN 0.9_CD mug/ml_NN with_IN an_DT EC50_NP of_IN 2.21_CD +-_NN 0.2_CD mug/ml_NN (_( mean_JJ +-_NN SEM_NP ,_, n_NN =_SYM 4_CD )_) ,_, which_WDT is_VBZ comparable_JJ to_TO other_JJ proteins_NNS previously_RB demonstrated_VBD to_TO regulate_VB secretion_NN in_IN these_DT cells_NNS ._SENT This_DT effect_NN on_IN secretion_NN is_VBZ unlikely_JJ to_TO be_VB due_JJ to_TO nonspecific_JJ protein_NN effects_NNS because_IN neither_DT boiled_VBN Secernin_NP 1_CD at_IN 10_CD mug/ml_NN nor_CC BSA_NP up_RB to_TO 1_CD mg/ml_NN had_VBD any_DT effect_NN on_IN secretion_NN from_IN these_DT cells_NNS (_( O'Sullivan_NP ,_, unpublished_JJ observations_NNS )_) ._SENT Figure_NN shows_VBZ the_DT effect_NN of_IN the_DT protein_NN at_IN various_JJ times_NNS of_IN rundown_NN ,_, the_DT protein_NN initially_RB has_VBZ no_DT effect_NN ,_, but_CC as_IN the_DT cytosol_NN leaks_NNS from_IN the_DT cells_NNS ,_, there_EX is_VBZ an_DT increasing_VBG effect_NN ,_, which_WDT in_IN turn_NN declines_NNS as_IN other_JJ proteins_NNS leak_VBP from_IN the_DT cell_NN ._SENT However_RB ,_, Secernin_NP 1_CD is_VBZ incapable_JJ of_IN completely_RB preventing_VBG rundown_NN ._SENT Figure_NP 4_CD |_SYM Secernin_NP 1_CD dose_NN response_NN ._SENT Secernin_NP 1_CD dose_NN response_NN ._SENT Mast_NN cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN of_IN varying_VBG concentrations_NNS of_IN Secernin_NP 1_CD ._SENT After_IN 15_CD min_NN the_DT cells_NNS were_VBD stimulated_VBN by_IN addition_NN of_IN solutions_NNS containing_VBG EGTA_NP buffered_VBD to_TO 10_CD muM_NN Ca2+_NP plus_CC GTPgammaS_NP (_( final_JJ concentration_NN ,_, 100_CD muM_NN )_) or_CC 100_CD nM_NN Ca2+_NP ._SENT After_IN a_DT further_RBR 20-min_JJ incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Stimulated_VBN secretion_NN is_VBZ calculated_VBN as_IN the_DT difference_NN in_IN the_DT amount_NN of_IN hexosaminidase_NN released_VBN in_IN response_NN to_TO either_RB 100_CD nM_NN Ca2+_NP or_CC 10_CD muM_NP Ca2+_NP +_SYM 100_CD muM_NN GTPgammaS_NNS ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT Figure_NP 5_CD |_SYM Effect_NN of_IN Secernin_NP on_IN rundown_NN of_IN secretory_JJ response_NN ._SENT Effect_NN of_IN Secernin_NP on_IN rundown_NN of_IN secretory_JJ response_NN ._SENT Mast_NN cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN (_( circle_NN )_) and_CC absence_NN of_IN Secernin_NP 1_CD at_IN a_DT final_JJ concentration_NN of_IN 3.5_CD mug/ml_NN ._SENT At_IN times_NNS indicated_VBD ,_, samples_NNS were_VBD removed_VBN and_CC stimulated_VBN by_IN transfer_NN to_TO solutions_NNS containing_VBG EGTA_NP buffered_VBD to_TO 10_CD muM_NN Ca2+_NP plus_CC GTPgammaS_NP (_( final_JJ concentration_NN ,_, 100_CD muM_NN )_) or_CC 100_CD nM_NN Ca2+_NP ._SENT After_IN a_DT further_RBR 20-min_JJ incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Stimulated_VBN secretion_NN is_VBZ the_DT difference_NN in_IN the_DT amount_NN of_IN hexosaminidase_NN released_VBN in_IN response_NN to_TO either_RB 100_CD nM_NN Ca2+_NP or_CC 10_CD muM_NP Ca2+_NP +_SYM 100_CD muM_NN GTPgammaS_NNS ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT To_TO determine_VB that_IN the_DT protein_NN is_VBZ present_JJ in_IN mast_NN cells_NNS ,_, a_DT rabbit_NN polyclonal_JJ antibody_NN SK1147_JJ was_VBD generated_VBN against_IN the_DT purified_VBN protein_NN ._SENT Figure_NP A_NP shows_VBZ a_DT Western_JJ blot_NN of_IN whole_JJ mast_NN cells_NNS demonstrating_VBG a_DT single_JJ immunoreactive_JJ band_NN at_IN 50_CD kDa_NNS ;_: a_DT similar_JJ result_NN was_VBD obtained_VBN with_IN a_DT second_JJ polyclonal_JJ antibody_NN SK1148_NP ._SENT The_DT results_NNS shown_VBN in_IN Figure_NN are_VBP consistent_JJ with_IN a_DT model_NN in_IN which_WDT Secernin_NP 1_CD leaks_NNS slowly_RB from_IN the_DT permeabilized_JJ cell_NN and_CC the_DT exogenously_RB added_VBN Secernin_NP 1_CD replaces_VBZ the_DT lost_JJ protein_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, supernatants_NNS were_VBD collected_VBN from_IN cells_NNS permeabilized_VBN over_IN increasing_VBG periods_NNS ._SENT The_DT supernatants_NNS were_VBD precipitated_VBN by_IN acetone_NN at_IN -20C_NN ,_, separated_VBN by_IN SDS-PAGE_NP ,_, and_CC analyzed_VBD by_IN Western_JJ blot_NN ._SENT Figure_NP B_NP shows_VBZ that_IN the_DT antibody_NN detects_VBZ an_DT increasing_VBG amount_NN of_IN the_DT 50-kDa_NP protein_NN in_IN the_DT supernatants_NNS with_IN time_NN after_IN permeabilization_NN ,_, confirming_VBG that_IN the_DT protein_NN is_VBZ cytosolic_JJ and_CC leaks_NNS from_IN the_DT cell_NN after_IN permeabilization_NN with_IN a_DT similar_JJ time_NN course_NN to_TO the_DT rundown_NN of_IN the_DT secretory_JJ response_NN ._SENT Figure_NP 6_CD |_SYM Presence_NN of_IN Secernin_NP in_IN mast_NN cell_NN cytosol_NN ._SENT Presence_NN of_IN Secernin_NP in_IN mast_NN cell_NN cytosol_NN ._SENT (_( A_NP )_) Western_JJ blot_NN of_IN intact_JJ mast_NN cells_NNS ._SENT After_IN transfer_NN to_TO nitrocellulose_NN membranes_NNS ,_, the_DT proteins_NNS were_VBD detected_VBN by_IN probing_VBG with_IN the_DT rabbit_NN polyclonal_JJ antibody_NN SK1147_JJ and_CC a_DT donkey_NN anti-rabbit_NN HRP_NP secondary_JJ antibody_NN visualized_VBN by_IN ECL_NP ._SENT (_( B_LS )_) The_DT permeabilized_JJ mast_NN cells_NNS were_VBD sampled_VBN at_IN the_DT times_NNS indicated_VBD and_CC rapidly_RB sedimented_JJ ._SENT Proteins_NNS present_JJ in_IN the_DT supernatants_NNS were_VBD precipitated_VBN and_CC Western_NP blotted_VBD ._SENT Proteins_NNS were_VBD detected_VBN with_IN antibody_NN SK1147_JJ ._SENT To_TO confirm_VB that_IN that_WDT the_DT effects_NNS of_IN Secernin_NP 1_CD were_VBD due_JJ to_TO the_DT 50-kDa_NP protein_NN the_DT anti-Secernin_NN antibody_NN ,_, SK1147_JJ was_VBD used_VBN to_TO immunoneutralize_VB the_DT purified_VBN protein_NN ._SENT Figure_NP A_NP shows_VBZ that_IN the_DT antibody_NN blocks_VBZ the_DT effect_NN of_IN the_DT optimal_JJ dose_NN of_IN Secernin_NP 1_CD ,_, whereas_IN same_JJ concentration_NN of_IN the_DT preimmune_NN sera_NN has_VBZ no_DT significant_JJ effect_NN ._SENT This_DT concentration_NN of_IN antibody_NN is_VBZ also_RB inhibits_VBZ the_DT effect_NN of_IN freshly_RB prepared_VBN rat_NN brain_NN cytosol_NN by_IN 50_CD %_NN ,_, indicating_VBG that_IN Secernin_NP is_VBZ responsible_JJ for_IN a_DT significant_JJ amount_NN of_IN the_DT activity_NN found_VBN in_IN whole_JJ cytosol_NN ._SENT To_TO confirm_VB that_IN this_DT effect_NN was_VBD due_JJ to_TO the_DT interaction_NN of_IN SK1147_JJ with_IN Secernin_NP ,_, the_DT antibody_NN was_VBD affinity_NN purified_VBN against_IN recombinant_JJ human_JJ Secernin_NP 1_CD ._SENT Figure_NP B_NP demonstrates_VBZ that_IN the_DT affinity-purified_JJ antibody_NN inhibits_VBZ fresh_JJ rat_NN brain_NN cytosol_NN and_CC that_IN this_DT inhibition_NN can_MD be_VB blocked_VBN by_IN inactive_JJ recombinant_JJ human_JJ Secernin_NP 1_CD in_IN an_DT inclusion_NN body_NN ._SENT Figure_NP 7_CD |_SYM Inhibition_NN of_IN Secernin_NP in_IN cytosol_NN by_IN anti-Secernin_NN antibody_NN ._SENT Inhibition_NN of_IN Secernin_NP in_IN cytosol_NN by_IN anti-Secernin_NN antibody_NN ._SENT (_( A_NP )_) Mast_NP cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN of_IN 10_CD mug/ml_NN purified_VBN Secernin_NP 1_CD or_CC 1_CD mg/ml_NN rat_NN brain_NN cytosol_NN ,_, which_WDT had_VBD been_VBN immunoneutralized_VBN with_IN SK1147_JJ antisera_NN ,_, preimmune_NN serum_NN ,_, or_CC sham_NN neutralized_VBN with_IN buffer_NN ._SENT After_IN 15_CD min_NN the_DT cells_NNS were_VBD stimulated_VBN by_IN addition_NN of_IN solutions_NNS containing_VBG EGTA_NP buffered_VBD to_TO 10_CD muM_NN Ca2+plus_NP GTPgammaS_NP (_( final_JJ concentration_NN ,_, 100_CD muM_NN )_) or_CC 100_CD nM_NN Ca2+After_NN a_DT further_JJR 20_CD min_NN incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Stimulated_VBN secretion_NN is_VBZ the_DT difference_NN in_IN the_DT amount_NN of_IN hexosaminidase_NN released_VBN in_IN response_NN to_TO either_RB 100_CD nM_NN Ca2+_NP or_CC 10_CD muM_NP Ca2+_NP +_SYM 100_CD muM_NN GTPgammaS_NNS ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT (_( B_NP )_) Mast_NP cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN or_CC absence_NN of_IN 1_CD mg/ml_NN rat_NN brain_NN cytosol_NN that_WDT had_VBD been_VBN immunoneutralized_VBN varying_VBG concentrations_NNS of_IN affinity-purified_JJ SK1147_JJ antisera_NN ,_, in_IN the_DT presence_NN and_CC absence_NN of_IN inclusion_NN bodies_NNS containing_VBG recombinant_JJ human_JJ Sescernin_NP 1_CD ._SENT After_IN 15_CD min_NN the_DT cells_NNS were_VBD stimulated_VBN by_IN addition_NN of_IN solutions_NNS containing_VBG EGTA_NP buffered_VBD to_TO 10_CD muM_NN Ca2+plus_NP GTPgammaS_NP (_( final_JJ concentration_NN ,_, 100_CD muM_NN )_) or_CC 100_CD nM_NN Ca2+_NP ._SENT After_IN a_DT further_RBR 20-min_JJ incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Stimulated_VBN secretion_NN is_VBZ the_DT difference_NN in_IN the_DT amount_NN of_IN hexosaminidase_NN released_VBN in_IN response_NN to_TO either_RB 100_CD nM_NN Ca2+_NP or_CC 10_CD muM_NP Ca2+_NP +_SYM 100_CD muM_NN GTPgammaS_NNS ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT Two_CD possible_JJ mechanisms_NNS for_IN Secernin_NP 1_CD to_TO increase_VB the_DT extent_NN of_IN secretion_NN would_MD be_VB to_TO increase_VB either_RB the_DT rate_NN of_IN secretion_NN or_CC to_TO allow_VB secretion_NN to_TO occur_VB over_RP a_DT much_RB longer_JJR period_NN ._SENT Figure_NN clearly_RB demonstrates_VBZ that_IN the_DT addition_NN of_IN Secernin_NP 1_CD to_TO the_DT cells_NNS during_IN rundown_NN ,_, before_IN stimulation_NN ,_, increases_VBZ the_DT rate_NN of_IN secretion_NN from_IN the_DT permeabilized_JJ mast_NN cells_NNS ._SENT If_IN the_DT data_NNS are_VBP normalized_VBN to_TO the_DT response_NN at_IN 25_CD min_NN ,_, as_RB shown_VBN in_IN the_DT inset_NN to_TO Figure_NN ,_, it_PP becomes_VBZ clear_JJ that_IN although_IN the_DT rate_NN of_IN secretion_NN is_VBZ increased_VBN by_IN Secernin_NP 1_CD ,_, the_DT time_NN course_NN of_IN the_DT secretory_JJ response_NN is_VBZ unaffected_JJ by_IN the_DT presence_NN of_IN Secernin_NP 1_CD ._SENT Figure_NP 8_CD |_SYM Effect_NN of_IN Secernin_NP on_IN the_DT time_NN course_NN of_IN secretion_NN ._SENT Effect_NN of_IN Secernin_NP on_IN the_DT time_NN course_NN of_IN secretion_NN ._SENT Mast_NN cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN or_CC absence_NN of_IN 3_CD mug/ml_NN purified_VBN Secernin_NP 1_CD ._SENT After_IN 15_CD min_NN the_DT cells_NNS were_VBD stimulated_VBN by_IN addition_NN of_IN solutions_NNS containing_VBG EGTA_NP buffered_VBD to_TO 10_CD muM_NN Ca2+plus_NP GTPgammaS_NP (_( final_JJ concentration_NN ,_, 100_CD muM_NN )_) ._SENT After_IN a_DT further_RBR 20-min_JJ incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 3_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT The_DT inset_NN figure_NN shows_VBZ the_DT same_JJ data_NNS normalized_VBD to_TO 100_CD %_NN response_NN for_IN each_DT of_IN the_DT conditions_NNS after_IN 25_CD min_NN secretion_NN ._SENT We_PP have_VBP previously_RB shown_VBN that_IN the_DT sensitivity_NN of_IN the_DT mast_NN cells_NNS to_TO both_DT Ca2+_NP and_CC GTPgammaS_NP declines_NNS as_IN a_DT consequence_NN of_IN the_DT rundown_NN of_IN the_DT secretory_JJ response_NN ._SENT Therefore_RB ,_, we_PP investigated_VBD the_DT possibility_NN that_IN Secernin_NP 1_CD not_RB only_RB increased_VBN the_DT rate_NN and_CC extent_NN of_IN secretion_NN ,_, but_CC also_RB had_VBD an_DT effect_NN on_IN the_DT sensitivity_NN of_IN the_DT mast_NN cells_NNS to_TO stimulation_NN with_IN both_DT Ca2+_NP and_CC GTPgammaS_NP ._SENT Figure_NP A_NP shows_VBZ the_DT effect_NN of_IN Secernin_NP on_IN the_DT GTPgammaS_NP sensitivity_NN of_IN cells_NNS in_IN the_DT presence_NN of_IN 0.1_CD and_CC 10_CD muM_NN Ca2+_NP ._SENT Under_IN these_DT rundown_JJ conditions_NNS ,_, all_DT concentrations_NNS of_IN GTPgammaS_NP in_IN the_DT presence_NN of_IN 0.1_CD muM_NN Ca2+_NN are_VBP incapable_JJ of_IN inducing_VBG secretion_NN ,_, whether_IN Secernin_NP 1_CD is_VBZ present_JJ or_CC not_RB ._SENT In_IN the_DT presence_NN of_IN 10_CD muM_NN Ca2+_NP Secernin_NP 1_CD increases_NNS the_DT extent_NN of_IN secretion_NN by_IN the_DT same_JJ amount_NN ,_, independent_JJ of_IN the_DT concentration_NN of_IN GTPgammaS_NP ._SENT Figure_NP B_NP clearly_RB demonstrates_VBZ that_IN Secernin_NP 1_CD partially_RB restores_VBZ the_DT Ca2+_NP sensitivity_NN of_IN the_DT rundown_JJ mast_NN cells_NNS ,_, with_IN some_DT Ca2+-dependent_NP secretion_NN even_RB occurring_VBG in_IN the_DT absence_NN of_IN GTPgammaS_NP ._SENT Figure_NP 9_CD |_SYM (_( A_NP and_CC B_NP )_) Effect_NN of_IN Secernin_NP on_IN the_DT sensitivity_NN of_IN mast_NN cell_NN secretion_NN to_TO Ca2+_NP and_CC GTPgammaS_NP ._SENT (_( A_NP and_CC B_NP )_) Effect_NN of_IN Secernin_NP on_IN the_DT sensitivity_NN of_IN mast_NN cell_NN secretion_NN to_TO Ca2+_NP and_CC GTPgammaS_NP ._SENT Mast_NN cells_NNS permeabilized_VBN with_IN SLO_NP in_IN the_DT presence_NN (_( filled_VBN symbols_NNS )_) or_CC absence_NN (_( open_JJ symbols_NNS )_) of_IN 3_CD mug/ml_NN Secernin_NP 1_CD ._SENT After_IN 15_CD min_NN the_DT cells_NNS were_VBD stimulated_VBN by_IN addition_NN of_IN solutions_NNS containing_VBG the_DT following_NN :_: (_( A_NP )_) EGTA_NP buffered_VBD to_TO either_RB 0.1_CD muM_NN (_( circle_NN ,_, )_) or_CC 10_CD muM_NN Ca2+_NN plus_CC varying_VBG concentrations_NNS of_IN GTPgammaS_NP or_CC (_( B_NP )_) EGTA_NP buffered_VBD to_TO varying_VBG concentrations_NNS of_IN Ca2+_NP plus_CC a_DT final_JJ concentration_NN of_IN either_DT 0_CD or_CC 100_CD muM_NN GTPgammaS_NNS ._SENT After_IN a_DT further_RBR 20-min_JJ incubation_NN ,_, the_DT cells_NNS were_VBD sedimented_VBN by_IN centrifugation_NN ,_, and_CC the_DT supernatants_NNS were_VBD sampled_VBN for_IN analysis_NN of_IN secreted_VBN hexosaminidase_NN ._SENT Data_NNS shown_VBN are_VBP mean_JJ +-_NN SEM_NP (_( n_NN =_SYM 4_CD )_) ;_: similar_JJ results_NNS were_VBD obtained_VBN on_IN four_CD occasions_NNS ._SENT Some_DT error_NN bars_NNS are_VBP smaller_JJR than_IN symbols_NNS used_VBN ._SENT We_PP have_VBP purified_VBN a_DT novel_JJ cytosolic_JJ protein_NN ,_, termed_VBN Secernin_NP 1_CD ,_, which_WDT regulates_VBZ exocytosis_NN in_IN permeabilized_JJ rat_NN peritoneal_JJ mast_NN cells_NNS ._SENT Database_NN analysis_NN reveals_VBZ that_IN fragments_NNS of_IN Secernin_NP 1_CD identified_VBN by_IN mass_JJ spectrometry_NN show_VBP 93.5_CD %_NN identity_NN and_CC 95.7_CD %_NN homology_NN with_IN the_DT predicted_VBN product_NN of_IN mouse_NN cDNA_NN ,_, which_WDT has_VBZ a_DT predicted_VBN MW_NN of_IN 46296_CD ,_, which_WDT is_VBZ consistent_JJ with_IN our_PP$ estimated_JJ molecular_JJ weight_NN of_IN 50_CD kDa_NN from_IN SDS-PAGE_NP 